What Is Selank? The Nootropic Peptide for Anxiety Research

What Is Selank?

Selank (CAS 129954-34-3, molecular weight 751.87 Da, sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is derived from tuftsin — an endogenous tetrapeptide (Thr-Lys-Pro-Arg) produced in the spleen that plays a role in immune signalling. Selank incorporates the full tuftsin sequence as its N-terminal core and adds a Pro-Gly-Pro tripeptide extension at the C-terminus. This modification slows carboxypeptidase-mediated degradation, extending the peptide's metabolic half-life while preserving tuftsin receptor activity.

In preclinical research, Selank has been most consistently studied for its anxiolytic effects — reducing anxiety-related behaviour in animal models without the sedation, motor impairment, or dependence profile associated with classical benzodiazepine compounds.

The Mechanism: GABA Modulation Without Benzodiazepine Binding

The primary proposed mechanism behind Selank's anxiolytic activity involves modulation of GABA-A receptor sensitivity. GABA (gamma-aminobutyric acid) is the brain's main inhibitory neurotransmitter. By enhancing GABA-A receptor activity without directly binding the benzodiazepine allosteric site, Selank appears to produce anxiolytic effects while avoiding the receptor desensitisation and tolerance that occurs with classical BZD use in chronic research models.

This is a key pharmacological distinction: benzodiazepines agonise the benzodiazepine binding site, leading to progressive receptor downregulation and dependence. Selank's indirect modulation mechanism may explain its different profile in dependence and withdrawal studies.

Key Research Areas

Anxiolytic Effects Without Sedation

In elevated plus maze (EPM) and light-dark box tests — the standard preclinical models for anxiety — Selank-treated animals show reduced anxiety-related behaviour consistent with benzodiazepine-class compounds. However, in rotarod coordination tests and open field locomotion assessments, Selank does not produce the motor impairment or sedation that accompanies conventional BZD-class compounds.

Memory and Cognitive Performance Under Stress

Selank has been studied in rodent models for its effects on memory consolidation and learning, particularly in stress-conditioned paradigms. Where classical anxiolytics often impair memory formation (a known side effect of benzodiazepine use), Selank in preclinical models has not produced this pattern — and in some paradigms has shown improvements in memory consolidation under stress conditions.

BDNF and NGF Upregulation

Research has documented Selank's ability to elevate BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) expression in hippocampal tissue. Both are critical regulators of neuroplasticity, synaptic strength, and long-term potentiation. BDNF upregulation is a shared feature with several other nootropic peptides, including Semax, but is achieved through different pathways.

Monoamine System Modulation

Selank interacts with serotonin and dopamine turnover in limbic brain regions. In stress models, it modulates elevated 5-HT and dopamine activity, which may be the mechanism through which it reduces anxiety-driven arousal without producing the sedation of compounds that broadly suppress these systems.

Immunomodulatory Activity

Via its tuftsin core, Selank retains interaction with tuftsin receptors on immune cells. This has led to research interest in its effects on cytokine balance, T-cell activity, and interferon production. The immune-modulating and CNS-modulating actions appear to be separable research targets.

Selank vs Semax: Two Distinct Nootropic Research Tools

Both are available from Peptide Warehouse as part of our nootropic peptide range. Many research protocols combine them in separate administrations to study calm-focus and activating-focus states independently.

Reconstitution and Storage

Reconstitute by adding 1–2mL of bacteriostatic water to the lyophilised vial. Inject BAC water slowly down the inside wall of the vial — do not aim at the powder. Swirl gently until dissolved. Store lyophilised at −20°C for up to 24 months. Store reconstituted solution at 2–8°C (refrigerator) for up to 4 weeks. Protect from light throughout.

Disclaimer: Selank is a research compound for in-vitro laboratory use only. It is not approved for human consumption, therapeutic, or veterinary use. All information in this article relates to preclinical research. Not for human use.